Looks like you clickedhttps://www.urotoday.com/conference-highlights/asco-2019-annual-meeting/asco-2019-prostate-cancer/112894-asco-2019-first-results-from-titan-a-phase-iii-double-blind-randomized-study-of-apalutamide-versus-placebo-in-patients-with-metastatic-castration-sensitive-prostate-cancer-receiving-androgen-deprivation-therapy.html
If you do not want to visit that page, you can close this browser tab.
